
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>T1D Genome Analysis Report - DEMO-SAMPLE</title>
    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.0/dist/css/bootstrap.min.css" rel="stylesheet">
    <style>
        body { padding: 20px; }
        .card { margin-bottom: 20px; }
        .badge { padding: 0.5em 0.75em; }
        .table th { position: sticky; top: 0; background: white; }
        .disclaimer { background-color: #fff3cd; padding: 15px; border-radius: 5px; margin-top: 20px; }
    </style>
</head>
<body>
    <div class="container-fluid">
        <header class="mb-4">
            <h1>Type 1 Diabetes Genome Analysis Report</h1>
            <p class="text-muted">
                Sample: DEMO-SAMPLE |
                Generated: 2026-01-11 14:45:44 |
                Analysis Version: 1.0
            </p>
        </header>

        
    <div class="card mb-4 border-primary">
        <div class="card-header bg-primary text-white">
            <h2>Executive Summary</h2>
        </div>
        <div class="card-body">
            <div class="row">
                <div class="col-md-4 text-center">
                    <h5>HLA-Based Risk</h5>
                    <div style="font-size: 1.8em; color: #dc3545; font-weight: bold;">
                        Very High
                    </div>
                    <div class="mt-2">
            <span style="font-size: 1.5em; font-weight: bold;">16.6×</span>
            <span class="text-muted">higher risk than general population</span>
            <br><small class="text-muted">(Odds Ratio from published research)</small>
        </div>
                </div>
                <div class="col-md-4">
                    <h5>HLA Markers</h5>
                    <div class="mb-2">
                        <strong class="text-danger">Risk:</strong> <span class="badge bg-danger me-1">DR3-DQ2 / DR4-DQ8</span>
                    </div>
                    <div>
                        <strong class="text-success">Protective:</strong> <span class="text-muted">None detected</span>
                    </div>
                    <small class="text-muted d-block mt-2">
                        Risk markers increase T1D likelihood; protective markers decrease it.
                    </small>
                </div>
                <div class="col-md-4">
                    <h5>Non-HLA Variants</h5>
                    
    <div class="text-center">
        <div style="font-size: 2.5em; font-weight: bold; color: #dc3545;">
            7 <span style="font-size: 0.5em; color: #6c757d;">of 9</span>
        </div>
        <p class="mb-1">known T1D risk variants</p>
        <small class="text-muted">More risk variants = higher genetic contribution</small>
    </div>
    
                </div>
            </div>
            
            
    <details class="mt-3">
        <summary><strong>Technical Details</strong> <small class="text-muted">(for researchers)</small></summary>
        <div class="mt-2 p-3 bg-light rounded">
            <h6>Non-HLA Genetic Risk Score (GRS)</h6>
            <ul class="mb-2">
                <li>Variants analyzed: 9</li>
                <li>Carrying risk allele: 7</li>
                <li><strong>Non-HLA GRS: 2.704</strong>
                    <span class="text-warning">(Above average)</span>
                </li>
            </ul>
            <p class="small text-muted mb-0">
                GRS calculated per Sharp et al. 2019: sum of (dosage × ln(OR)) for each variant.
                <a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank">PMID:30655379</a>
            </p>
        </div>
    </details>
    
        </div>
    </div>
    

        <ul class="nav nav-tabs mb-4" id="reportTabs" role="tablist">
            <li class="nav-item">
                <a class="nav-link active" data-bs-toggle="tab" href="#hla">HLA Analysis</a>
            </li>
            <li class="nav-item">
                <a class="nav-link" data-bs-toggle="tab" href="#priority">Priority Variants</a>
            </li>
            <li class="nav-item">
                <a class="nav-link" data-bs-toggle="tab" href="#gwas">GWAS Variants</a>
            </li>
        </ul>

        <div class="tab-content">
            <div class="tab-pane fade show active" id="hla">
                
    <div class="card mb-4">
        <div class="card-body">
            <div class="row align-items-center">
                <div class="col-md-8">
                    <h5 class="mb-2">Your HLA Type</h5>
                    <p class="lead mb-0">DR3-DQ2<br>DR4-DQ8 (*04:01)</p>
                </div>
                <div class="col-md-4">
                    <h6>HLA Markers</h6>
                    <div class="mb-1">
                        <strong class="text-danger">Risk:</strong> <span class="badge bg-danger me-1">DR3-DQ2 / DR4-DQ8</span>
                    </div>
                    <div>
                        <strong class="text-success">Protective:</strong> <span class="text-muted">None</span>
                    </div>
                </div>
            </div>
        </div>
    </div>
    
                
    <div class="card mb-4">
        <div class="card-header">
            <h3>HLA-Based T1D Risk Assessment</h3>
            <small class="text-muted">Source: Erlich et al. (2008) Diabetes 57(4):1084-1092</small>
        </div>
        <div class="card-body">
            <div class="row">
                <div class="col-md-6">
                    <h4>Genotype</h4>
                    <table class="table table-sm">
                        <thead>
                            <tr><th>Gene</th><th>Alleles</th></tr>
                        </thead>
                        <tbody>
                            <tr><td>HLA-A</td><td>A*02:01 / A*24:02</td></tr>
<tr><td>HLA-B</td><td>B*08:01 / B*44:02</td></tr>
<tr><td>HLA-C</td><td>C*07:01 / C*05:01</td></tr>
<tr><td>HLA-DQA1</td><td>DQA1*05:01 / DQA1*03:01</td></tr>
<tr><td>HLA-DQB1</td><td>DQB1*02:01 / DQB1*03:02</td></tr>
<tr><td>HLA-DRB1</td><td>DRB1*03:01 / DRB1*04:01</td></tr>

                        </tbody>
                    </table>
                </div>
                <div class="col-md-6">
                    <h4>Risk Assessment</h4>
                    <p>
                        <span class="badge" style="background-color: #dc3545; font-size: 1.2em;">
                            Very High
                        </span>
                    </p>
                    <p><strong>Odds Ratio:</strong> 16.59</p>
                    <p><strong>Source:</strong> <small>Erlich 2008 (DR3/DR4 heterozygote genotype)</small></p>
                    <p><strong>Interpretation:</strong> DR3/DR4 heterozygote - highest genetic risk for T1D</p>

                    <h5>Risk Factors</h5>
                    <ul>
                        <li>DR3/DR4 Heterozygote: Yes</li>
                        <li>Has DR3: Yes</li>
                        <li>Has DR4: Yes (*04:01)</li>
                        <li>Has DQ2: Yes</li>
                        <li>Has DQ8: Yes</li>
                        <li>Protective Alleles: None</li>
                    </ul>
                </div>
            </div>

            <h4>Identified Haplotypes</h4>
            <ul><li>DR3-DQ2</li>
<li>DR4-DQ8 (*04:01)</li>
</ul>
            <p class="text-muted small mb-0">
                Haplotypes pair your <strong>DRB1</strong> + <strong>DQB1</strong> alleles based on known linkage patterns.
                <span class="badge bg-warning text-dark">ATYPICAL</span> = uncommon pairing, may lack published risk data.
            </p>

            <h4>Important Notes</h4><ul class='text-warning'><li>This is the highest-risk HLA genotype for T1D</li>
<li>DR3/DR4 heterozygotes have ~16x increased risk compared to general population</li>
<li>Both DQ2 (DQB1*02:01) and DQ8 (DQB1*03:02) are present</li>
</ul>
        </div>
    </div>
    
                
                
    <div class="card mb-4">
        <div class="card-header bg-light d-flex justify-content-between align-items-center"
             style="cursor: pointer;"
             data-bs-toggle="collapse"
             data-bs-target="#decoderCollapse"
             aria-expanded="false">
            <div>
                <h5 class="mb-0">HLA Nomenclature Guide</h5>
                <small class="text-muted">Understanding the allele codes</small>
            </div>
            <span class="text-muted">▼ Click to expand</span>
        </div>
        <div class="collapse" id="decoderCollapse">
        <div class="card-body">
            <!-- Explain the naming system first -->
            <div class="alert alert-info mb-4">
                <h6 class="alert-heading mb-2">How to read HLA codes</h6>
                <p class="mb-2">Example: <code>DRB1*04:01</code></p>
                <ul class="mb-0">
                    <li><strong>DRB1</strong> = the gene name (on chromosome 6)</li>
                    <li><strong>*04</strong> = the allele group (this is "DR4")</li>
                    <li><strong>:01</strong> = the specific protein variant within DR4</li>
                </ul>
                <p class="mt-2 mb-0"><em>Think of it like software versions: DR4 is the major version, :01/:02/:05 are minor variants that behave similarly.</em></p>
            </div>

            <div class="row">
                <div class="col-md-6">
                    <h6>DRB1 Alleles (DR types)</h6>
                    <table class="table table-sm">
                        <thead><tr><th>Name</th><th>What it means</th><th>T1D Risk</th></tr></thead>
                        <tbody>
                            <tr>
                                <td><strong>DR3</strong></td>
                                <td>Any DRB1*03:xx allele<br><small class="text-muted">e.g., *03:01</small></td>
                                <td><span class="badge bg-danger">High Risk</span></td>
                            </tr>
                            <tr>
                                <td><strong>DR4</strong></td>
                                <td>Any DRB1*04:xx allele<br><small class="text-muted">e.g., *04:01, *04:02, *04:05</small></td>
                                <td><span class="badge bg-danger">High Risk</span></td>
                            </tr>
                            <tr>
                                <td><strong>DR13</strong></td>
                                <td>Any DRB1*13:xx allele<br><small class="text-muted">e.g., *13:01, *13:02</small></td>
                                <td><span class="badge bg-secondary">Neutral</span></td>
                            </tr>
                            <tr>
                                <td><strong>DR15</strong></td>
                                <td>Any DRB1*15:xx allele<br><small class="text-muted">e.g., *15:01</small></td>
                                <td><span class="badge bg-success">Protective</span></td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                <div class="col-md-6">
                    <h6>DQB1 Alleles (DQ types)</h6>
                    <table class="table table-sm">
                        <thead><tr><th>Name</th><th>What it means</th><th>T1D Risk</th></tr></thead>
                        <tbody>
                            <tr>
                                <td><strong>DQ2</strong></td>
                                <td>DQB1*02:01<br><small class="text-muted">presents gluten & insulin peptides</small></td>
                                <td><span class="badge bg-danger">High Risk</span></td>
                            </tr>
                            <tr>
                                <td><strong>DQ8</strong></td>
                                <td>DQB1*03:02<br><small class="text-muted">presents insulin peptides to T cells</small></td>
                                <td><span class="badge bg-danger">High Risk</span></td>
                            </tr>
                            <tr>
                                <td><strong>DQ6</strong></td>
                                <td>Any DQB1*06:xx allele<br><small class="text-muted">e.g., *06:02, *06:04</small></td>
                                <td><span class="badge bg-success">Protective</span></td>
                            </tr>
                        </tbody>
                    </table>
                </div>
            </div>

            <!-- Explain the synergistic risk -->
            <div class="alert alert-danger mt-3 mb-0">
                <h6 class="alert-heading">Why DR3/DR4 combination is highest risk</h6>
                <p class="mb-2">Having <strong>both</strong> DR3-DQ2 and DR4-DQ8 (one from each parent) creates ~16x risk - more than either alone. Why?</p>
                <ul class="mb-0">
                    <li><strong>DQ2</strong> and <strong>DQ8</strong> each present different insulin peptides to immune cells</li>
                    <li>Together, they activate a broader range of autoreactive T cells</li>
                    <li>This "double attack" on beta cells is more destructive than either alone</li>
                </ul>
            </div>
        </div>
        </div><!-- end collapse -->
    </div>
    
            </div>
            <div class="tab-pane fade" id="priority">
                
    <div class="card mb-4">
        <div class="card-header">
            <h3>Priority Variants</h3>
        </div>
        <div class="card-body">
            <div class="table-responsive">
                <table class="table table-striped table-sm">
                    <thead>
                        <tr><th>Chr</th><th>Position</th><th>Ref</th><th>Alt</th><th>Gene</th><th>rsID</th><th>Effect</th><th><span data-bs-toggle="tooltip" data-bs-placement="top" title="Your genotype at this position. 0/0 = no variant, 0/1 = one copy, 1/1 = two copies. * indicates inferred from reference." style="cursor:help; border-bottom:1px dotted #666;">Genotype</span></th><th><span data-bs-toggle="tooltip" data-bs-placement="top" title="Number of risk alleles you carry: 0 (none), 1 (one copy), or 2 (two copies)." style="cursor:help; border-bottom:1px dotted #666;">Dosage</span></th><th><span data-bs-toggle="tooltip" data-bs-placement="top" title="Odds Ratio from published T1D GWAS studies. Values &gt;1 mean increased risk; &lt;1 mean protective. Click 'Source' for citation." style="cursor:help; border-bottom:1px dotted #666;">OR</span></th><th><span data-bs-toggle="tooltip" data-bs-placement="top" title="Genetic Risk Score contribution = number of risk alleles × ln(OR). Higher values = more risk." style="cursor:help; border-bottom:1px dotted #666;">GRS</span></th><th><span data-bs-toggle="tooltip" data-bs-placement="top" title="Effect allele frequency in Latino/Admixed American population (gnomAD v4.1). This is the frequency of the T1D-associated allele. Note: gnomAD reports ALT allele freq; we convert to effect allele freq when effect allele = REF." style="cursor:help; border-bottom:1px dotted #666;">Effect AF (AMR)</span></th><th><span data-bs-toggle="tooltip" data-bs-placement="top" title="Clinical significance for GENERAL health effects (not T1D-specific). Most T1D risk variants are 'benign' for other diseases but still affect T1D through immune pathways." style="cursor:help; border-bottom:1px dotted #666;">ClinVar</span></th><th>Priority</th><th>Source</th></tr>
                    </thead>
                    <tbody>
                        <tr><td>chr1</td><td>114377568</td><td>G</td><td>A</td><td><span data-bs-toggle="tooltip" data-bs-placement="top" title="Protein tyrosine phosphatase - regulates T cell receptor signaling. Risk variant causes gain-of-function, reducing T cell activation threshold." style="cursor:help; border-bottom:1px dotted #666;">PTPN22</span></td><td>rs2476601</td><td>R620W</td><td>0/1</td><td>1</td><td>1.96x</td><td><span class="text-danger">+0.670</span></td><td><span class="text-muted">10.0%</span></td><td><span class="badge bg-success">benign</span></td><td><span class="badge bg-danger ">High Priority</span></td><td><a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank" title="View on PubMed">PMID:30655379</a></td></tr>
<tr><td>chr11</td><td>2182224</td><td>T</td><td>A</td><td><span data-bs-toggle="tooltip" data-bs-placement="top" title="Insulin gene - additional T1D-associated variant in INS locus, affects insulin expression regulation." style="cursor:help; border-bottom:1px dotted #666;">INS</span></td><td>rs689</td><td>VNTR</td><td>0/1</td><td>1</td><td>1.81x</td><td><span class="text-danger">+0.590</span></td><td><span class="text-muted">28.0%</span></td><td><span class="badge bg-success">benign</span></td><td><span class="badge bg-danger ">High Priority</span></td><td><a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank" title="View on PubMed">PMID:30655379</a></td></tr>
<tr><td>chr10</td><td>6074707</td><td>A</td><td>T</td><td><span data-bs-toggle="tooltip" data-bs-placement="top" title="IL-2 receptor alpha - protective variant affecting IL2RA expression and Treg function." style="cursor:help; border-bottom:1px dotted #666;">IL2RA</span></td><td>rs11594656</td><td>Regulatory</td><td>0/1</td><td>1</td><td>1.50x</td><td><span class="text-danger">+0.410</span></td><td><span class="text-muted">65.0%</span></td><td><span class="badge bg-success">benign</span></td><td><span class="badge bg-danger ">High Priority</span></td><td><a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank" title="View on PubMed">PMID:30655379</a></td></tr>
<tr><td>chr2</td><td>204738919</td><td>G</td><td>A</td><td><span data-bs-toggle="tooltip" data-bs-placement="top" title="Cytotoxic T-lymphocyte antigen 4 - inhibitory checkpoint receptor. Variants reduce CTLA4 expression, enhancing T cell activation." style="cursor:help; border-bottom:1px dotted #666;">CTLA4</span></td><td>rs3087243</td><td>3'UTR</td><td>0/0</td><td>2</td><td>1.20x</td><td><span class="text-danger">+0.360</span></td><td><span class="text-muted">54.0%</span></td><td><span class="badge bg-success">benign</span></td><td><span class="badge bg-danger ">High Priority</span></td><td><a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank" title="View on PubMed">PMID:30655379</a></td></tr>
<tr><td>chr12</td><td>111884608</td><td>T</td><td>C</td><td><span data-bs-toggle="tooltip" data-bs-placement="top" title="Adaptor protein (LNK) - regulates cytokine signaling and hematopoiesis. Risk variant increases inflammatory responses." style="cursor:help; border-bottom:1px dotted #666;">SH2B3</span></td><td>rs3184504</td><td>W262R</td><td>0/1</td><td>1</td><td>1.30x</td><td><span class="text-danger">+0.260</span></td><td><span class="text-muted">50.0%</span></td><td><span class="badge bg-success">benign</span></td><td><span class="badge bg-danger ">High Priority</span></td><td><a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank" title="View on PubMed">PMID:30655379</a></td></tr>
<tr><td>chr12</td><td>56482028</td><td>T</td><td>G</td><td><span data-bs-toggle="tooltip" data-bs-placement="top" title="ErbB3 receptor - growth factor signaling in pancreatic beta cells. May affect beta cell survival/regeneration." style="cursor:help; border-bottom:1px dotted #666;">ERBB3</span></td><td>rs2292239</td><td>Intronic</td><td>0/1</td><td>1</td><td>1.25x</td><td><span class="text-danger">+0.220</span></td><td><span class="text-muted">65.0%</span></td><td><span class="badge bg-success">benign</span></td><td><span class="badge bg-danger ">High Priority</span></td><td><a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank" title="View on PubMed">PMID:30655379</a></td></tr>
<tr><td>chr16</td><td>11179873</td><td>A</td><td>G</td><td><span data-bs-toggle="tooltip" data-bs-placement="top" title="C-type lectin - regulates autophagy and mitophagy. Affects thymic selection and beta cell function." style="cursor:help; border-bottom:1px dotted #666;">CLEC16A</span></td><td>rs12708716</td><td>Intronic</td><td>0/1</td><td>1</td><td>1.20x</td><td><span class="text-danger">+0.180</span></td><td><span class="text-muted">35.0%</span></td><td><span class="badge bg-success">benign</span></td><td><span class="badge bg-danger ">High Priority</span></td><td><a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank" title="View on PubMed">PMID:30655379</a></td></tr>

                    </tbody>
                </table>
            </div>
            
            
    <div class="alert alert-light border mt-3" role="alert">
        <strong>About this data:</strong>
        <ul class="mb-0 mt-2">
            <li><strong>Odds Ratios (OR)</strong> come from peer-reviewed genome-wide association studies (GWAS). Click "Source" to see the original publication.</li>
            <li><strong>Effect AF</strong> shows how common the effect (risk/protective) allele is in the general population. We convert gnomAD's ALT allele frequency to effect allele frequency when they differ.</li>
            <li><strong>ClinVar</strong> shows clinical significance for <em>general</em> health effects. Most T1D variants are "benign" for other conditions but still affect T1D risk through immune system pathways.</li>
        </ul>
    </div>
    
            
    <details class="mt-3">
        <summary><strong>Column Definitions & GRS Methodology</strong> <small class="text-muted">(click to expand)</small></summary>
        <div class="mt-2 p-3 bg-light rounded">
            <h6>Column Definitions</h6>
            <ul class="mb-3">
                <li><strong>Gene</strong>: Hover over gene name to see its function in T1D pathogenesis</li>
                <li><strong>Effect</strong>: Variant consequence - amino acid change (e.g., R620W = Arginine→Tryptophan at position 620) or genomic location (Intronic, 3'UTR, Regulatory, VNTR)</li>
                <li><strong>OR</strong>: Odds Ratio from GWAS. OR &gt;1 = increased risk, OR &lt;1 = protective</li>
                <li><strong>Genotype</strong>: Your genotype (0/0 = ref/ref, 0/1 = het, 1/1 = hom alt). <em>0/0* indicates inferred homozygous reference (position not in VCF variant calls)</em></li>
                <li><strong>Dosage</strong>: Number of risk alleles carried (0, 1, or 2)</li>
                <li><strong>GRS</strong>: Genetic Risk Score contribution for this variant</li>
                <li><strong>Effect AF (AMR)</strong>: Effect allele frequency in Latino/Admixed American population from gnomAD v4.1 (via DRAGEN Nirvana). Note: gnomAD reports ALT allele frequency, so when the GWAS effect allele is the REF allele, we display (1 - ALT freq) to show the true frequency of the risk allele.</li>
                <li><strong>ClinVar</strong>: Clinical significance from ClinVar database (benign, pathogenic, uncertain significance)</li>
            </ul>
            <h6>GRS Calculation (Sharp et al. 2019)</h6>
            <p class="mb-2">The Genetic Risk Score is calculated using the validated T1D GRS2 methodology:</p>
            <div class="alert alert-info py-2 mb-2">
                <code>GRS contribution = Dosage × ln(OR)</code>
            </div>
            <ul class="mb-2">
                <li><strong>Dosage</strong>: Number of risk alleles (0, 1, or 2)</li>
                <li><strong>ln(OR)</strong>: Natural log of the odds ratio (β coefficient)</li>
                <li><strong>Total GRS</strong>: Sum of all individual GRS contributions</li>
            </ul>
            <p class="mb-0 text-muted"><small>Reference: Sharp SA, et al. (2019) Diabetes Care 42:200-207. <a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank">PMID:30655379</a></small></p>
        </div>
    </details>
    
        </div>
    </div>
    
            </div>
            <div class="tab-pane fade" id="gwas">
                
    <div class="card mb-4">
        <div class="card-header">
            <h3>Known T1D GWAS Variants</h3>
        </div>
        <div class="card-body">
            <div class="table-responsive">
                <table class="table table-striped table-sm">
                    <thead>
                        <tr><th>Chr</th><th>Position</th><th>Ref</th><th>Alt</th><th>Gene</th><th>rsID</th><th>Effect</th><th><span data-bs-toggle="tooltip" data-bs-placement="top" title="Your genotype at this position. 0/0 = no variant, 0/1 = one copy, 1/1 = two copies. * indicates inferred from reference." style="cursor:help; border-bottom:1px dotted #666;">Genotype</span></th><th><span data-bs-toggle="tooltip" data-bs-placement="top" title="Number of risk alleles you carry: 0 (none), 1 (one copy), or 2 (two copies)." style="cursor:help; border-bottom:1px dotted #666;">Dosage</span></th><th><span data-bs-toggle="tooltip" data-bs-placement="top" title="Odds Ratio from published T1D GWAS studies. Values &gt;1 mean increased risk; &lt;1 mean protective. Click 'Source' for citation." style="cursor:help; border-bottom:1px dotted #666;">OR</span></th><th><span data-bs-toggle="tooltip" data-bs-placement="top" title="Genetic Risk Score contribution = number of risk alleles × ln(OR). Higher values = more risk." style="cursor:help; border-bottom:1px dotted #666;">GRS</span></th><th><span data-bs-toggle="tooltip" data-bs-placement="top" title="Effect allele frequency in Latino/Admixed American population (gnomAD v4.1). This is the frequency of the T1D-associated allele. Note: gnomAD reports ALT allele freq; we convert to effect allele freq when effect allele = REF." style="cursor:help; border-bottom:1px dotted #666;">Effect AF (AMR)</span></th><th><span data-bs-toggle="tooltip" data-bs-placement="top" title="Clinical significance for GENERAL health effects (not T1D-specific). Most T1D risk variants are 'benign' for other diseases but still affect T1D through immune pathways." style="cursor:help; border-bottom:1px dotted #666;">ClinVar</span></th><th>Priority</th><th>Source</th></tr>
                    </thead>
                    <tbody>
                        <tr><td>chr1</td><td>114377568</td><td>G</td><td>A</td><td><span data-bs-toggle="tooltip" data-bs-placement="top" title="Protein tyrosine phosphatase - regulates T cell receptor signaling. Risk variant causes gain-of-function, reducing T cell activation threshold." style="cursor:help; border-bottom:1px dotted #666;">PTPN22</span></td><td>rs2476601</td><td>R620W</td><td>0/1</td><td>1</td><td>1.96x</td><td><span class="text-danger">+0.670</span></td><td><span class="text-muted">10.0%</span></td><td><span class="badge bg-success">benign</span></td><td><span class="badge bg-danger ">High Priority</span></td><td><a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank" title="View on PubMed">PMID:30655379</a></td></tr>
<tr><td>chr11</td><td>2182224</td><td>T</td><td>A</td><td><span data-bs-toggle="tooltip" data-bs-placement="top" title="Insulin gene - additional T1D-associated variant in INS locus, affects insulin expression regulation." style="cursor:help; border-bottom:1px dotted #666;">INS</span></td><td>rs689</td><td>VNTR</td><td>0/1</td><td>1</td><td>1.81x</td><td><span class="text-danger">+0.590</span></td><td><span class="text-muted">28.0%</span></td><td><span class="badge bg-success">benign</span></td><td><span class="badge bg-danger ">High Priority</span></td><td><a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank" title="View on PubMed">PMID:30655379</a></td></tr>
<tr><td>chr10</td><td>6074707</td><td>A</td><td>T</td><td><span data-bs-toggle="tooltip" data-bs-placement="top" title="IL-2 receptor alpha - protective variant affecting IL2RA expression and Treg function." style="cursor:help; border-bottom:1px dotted #666;">IL2RA</span></td><td>rs11594656</td><td>Regulatory</td><td>0/1</td><td>1</td><td>1.50x</td><td><span class="text-danger">+0.410</span></td><td><span class="text-muted">65.0%</span></td><td><span class="badge bg-success">benign</span></td><td><span class="badge bg-danger ">High Priority</span></td><td><a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank" title="View on PubMed">PMID:30655379</a></td></tr>
<tr><td>chr2</td><td>204738919</td><td>G</td><td>A</td><td><span data-bs-toggle="tooltip" data-bs-placement="top" title="Cytotoxic T-lymphocyte antigen 4 - inhibitory checkpoint receptor. Variants reduce CTLA4 expression, enhancing T cell activation." style="cursor:help; border-bottom:1px dotted #666;">CTLA4</span></td><td>rs3087243</td><td>3'UTR</td><td>0/0</td><td>2</td><td>1.20x</td><td><span class="text-danger">+0.360</span></td><td><span class="text-muted">54.0%</span></td><td><span class="badge bg-success">benign</span></td><td><span class="badge bg-danger ">High Priority</span></td><td><a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank" title="View on PubMed">PMID:30655379</a></td></tr>
<tr><td>chr2</td><td>163124051</td><td>C</td><td>T</td><td><span data-bs-toggle="tooltip" data-bs-placement="top" title="Interferon-induced helicase - viral RNA sensor. Risk variant may alter antiviral responses triggering autoimmunity." style="cursor:help; border-bottom:1px dotted #666;">IFIH1</span></td><td>rs1990760</td><td>A946T</td><td>0/0</td><td>0</td><td>1.20x</td><td>0.000</td><td><span class="text-muted">41.0%</span></td><td><span class="badge bg-success">benign</span></td><td><span class="badge bg-success ">No Risk Allele</span></td><td><a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank" title="View on PubMed">PMID:30655379</a></td></tr>
<tr><td>chr12</td><td>111884608</td><td>T</td><td>C</td><td><span data-bs-toggle="tooltip" data-bs-placement="top" title="Adaptor protein (LNK) - regulates cytokine signaling and hematopoiesis. Risk variant increases inflammatory responses." style="cursor:help; border-bottom:1px dotted #666;">SH2B3</span></td><td>rs3184504</td><td>W262R</td><td>0/1</td><td>1</td><td>1.30x</td><td><span class="text-danger">+0.260</span></td><td><span class="text-muted">50.0%</span></td><td><span class="badge bg-success">benign</span></td><td><span class="badge bg-danger ">High Priority</span></td><td><a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank" title="View on PubMed">PMID:30655379</a></td></tr>
<tr><td>chr19</td><td>10469975</td><td>G</td><td>C</td><td><span data-bs-toggle="tooltip" data-bs-placement="top" title="Tyrosine kinase 2 - JAK family member in IFN/IL signaling. Variant affects cytokine-mediated immune responses." style="cursor:help; border-bottom:1px dotted #666;">TYK2</span></td><td>rs34536443</td><td>P1104A</td><td>0/0</td><td>0</td><td>1.30x</td><td>0.000</td><td><span class="text-info">4.00%</span></td><td><span class="badge bg-success">likely_benign</span></td><td><span class="badge bg-success ">No Risk Allele</span></td><td><a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank" title="View on PubMed">PMID:30655379</a></td></tr>
<tr><td>chr12</td><td>56482028</td><td>T</td><td>G</td><td><span data-bs-toggle="tooltip" data-bs-placement="top" title="ErbB3 receptor - growth factor signaling in pancreatic beta cells. May affect beta cell survival/regeneration." style="cursor:help; border-bottom:1px dotted #666;">ERBB3</span></td><td>rs2292239</td><td>Intronic</td><td>0/1</td><td>1</td><td>1.25x</td><td><span class="text-danger">+0.220</span></td><td><span class="text-muted">65.0%</span></td><td><span class="badge bg-success">benign</span></td><td><span class="badge bg-danger ">High Priority</span></td><td><a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank" title="View on PubMed">PMID:30655379</a></td></tr>
<tr><td>chr16</td><td>11179873</td><td>A</td><td>G</td><td><span data-bs-toggle="tooltip" data-bs-placement="top" title="C-type lectin - regulates autophagy and mitophagy. Affects thymic selection and beta cell function." style="cursor:help; border-bottom:1px dotted #666;">CLEC16A</span></td><td>rs12708716</td><td>Intronic</td><td>0/1</td><td>1</td><td>1.20x</td><td><span class="text-danger">+0.180</span></td><td><span class="text-muted">35.0%</span></td><td><span class="badge bg-success">benign</span></td><td><span class="badge bg-danger ">High Priority</span></td><td><a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank" title="View on PubMed">PMID:30655379</a></td></tr>

                    </tbody>
                </table>
            </div>
            
            
    <div class="alert alert-light border mt-3" role="alert">
        <strong>About this data:</strong>
        <ul class="mb-0 mt-2">
            <li><strong>Odds Ratios (OR)</strong> come from peer-reviewed genome-wide association studies (GWAS). Click "Source" to see the original publication.</li>
            <li><strong>Effect AF</strong> shows how common the effect (risk/protective) allele is in the general population. We convert gnomAD's ALT allele frequency to effect allele frequency when they differ.</li>
            <li><strong>ClinVar</strong> shows clinical significance for <em>general</em> health effects. Most T1D variants are "benign" for other conditions but still affect T1D risk through immune system pathways.</li>
        </ul>
    </div>
    
            
    <details class="mt-3">
        <summary><strong>Column Definitions & GRS Methodology</strong> <small class="text-muted">(click to expand)</small></summary>
        <div class="mt-2 p-3 bg-light rounded">
            <h6>Column Definitions</h6>
            <ul class="mb-3">
                <li><strong>Gene</strong>: Hover over gene name to see its function in T1D pathogenesis</li>
                <li><strong>Effect</strong>: Variant consequence - amino acid change (e.g., R620W = Arginine→Tryptophan at position 620) or genomic location (Intronic, 3'UTR, Regulatory, VNTR)</li>
                <li><strong>OR</strong>: Odds Ratio from GWAS. OR &gt;1 = increased risk, OR &lt;1 = protective</li>
                <li><strong>Genotype</strong>: Your genotype (0/0 = ref/ref, 0/1 = het, 1/1 = hom alt). <em>0/0* indicates inferred homozygous reference (position not in VCF variant calls)</em></li>
                <li><strong>Dosage</strong>: Number of risk alleles carried (0, 1, or 2)</li>
                <li><strong>GRS</strong>: Genetic Risk Score contribution for this variant</li>
                <li><strong>Effect AF (AMR)</strong>: Effect allele frequency in Latino/Admixed American population from gnomAD v4.1 (via DRAGEN Nirvana). Note: gnomAD reports ALT allele frequency, so when the GWAS effect allele is the REF allele, we display (1 - ALT freq) to show the true frequency of the risk allele.</li>
                <li><strong>ClinVar</strong>: Clinical significance from ClinVar database (benign, pathogenic, uncertain significance)</li>
            </ul>
            <h6>GRS Calculation (Sharp et al. 2019)</h6>
            <p class="mb-2">The Genetic Risk Score is calculated using the validated T1D GRS2 methodology:</p>
            <div class="alert alert-info py-2 mb-2">
                <code>GRS contribution = Dosage × ln(OR)</code>
            </div>
            <ul class="mb-2">
                <li><strong>Dosage</strong>: Number of risk alleles (0, 1, or 2)</li>
                <li><strong>ln(OR)</strong>: Natural log of the odds ratio (β coefficient)</li>
                <li><strong>Total GRS</strong>: Sum of all individual GRS contributions</li>
            </ul>
            <p class="mb-0 text-muted"><small>Reference: Sharp SA, et al. (2019) Diabetes Care 42:200-207. <a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank">PMID:30655379</a></small></p>
        </div>
    </details>
    
        </div>
    </div>
    
            </div>
        </div>

        <div class="card mb-4">
            <div class="card-header">
                <h3>Data Sources &amp; References</h3>
            </div>
            <div class="card-body">
                <h5>HLA Risk Assessment</h5>
                <ul>
                    <li>Erlich H, et al. (2008) HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk: Analysis of the Type 1 Diabetes Genetics Consortium Families. <em>Diabetes</em> 57(4):1084-1092.
                        <a href="https://pubmed.ncbi.nlm.nih.gov/18252895/" target="_blank">PMID:18252895</a></li>
                </ul>
                <h5>GWAS Variants</h5>
                <ul>
                    <li>Sharp SA, et al. (2019) Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis. <em>Diabetes Care</em> 42:200-207.
                        <a href="https://pubmed.ncbi.nlm.nih.gov/30655379/" target="_blank">PMID:30655379</a></li>
                    <li>Robertson CC, et al. (2021) Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes. <em>Nature Genetics</em> 53:962-971.
                        <a href="https://pubmed.ncbi.nlm.nih.gov/34127860/" target="_blank">PMID:34127860</a></li>
                </ul>
                <p class="text-muted mb-0"><small>Individual variant citations are linked in the "Source" column of the variant tables above.</small></p>
            </div>
        </div>

        <div class="disclaimer">
            <h5>Important Disclaimer</h5>
            <p>
                This report is for <strong>research and educational purposes only</strong>.
                It is not intended to provide medical advice, diagnosis, or treatment recommendations.
                Genetic risk assessment is complex and should be interpreted by qualified healthcare
                professionals in the context of clinical history and other factors.
            </p>
            <p>
                The odds ratios and risk categories presented are based on population-level studies
                and may not accurately predict individual disease risk. Many individuals with
                high-risk HLA genotypes never develop Type 1 Diabetes, and some with low-risk
                genotypes do develop the disease.
            </p>
        </div>

        <footer class="mt-4 text-muted">
            <p>
                Generated using T1D Genome Analysis Pipeline |
                <a href="https://github.com/dddiaz/type-1-diabetes-genome-analysis">GitHub</a>
            </p>
        </footer>
    </div>

    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.0/dist/js/bootstrap.bundle.min.js"></script>
    <script>
        // Initialize Bootstrap tooltips
        var tooltipTriggerList = [].slice.call(document.querySelectorAll('[data-bs-toggle="tooltip"]'))
        var tooltipList = tooltipTriggerList.map(function (tooltipTriggerEl) {
            return new bootstrap.Tooltip(tooltipTriggerEl)
        })
    </script>
</body>
</html>
    